Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes » Control

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

What Is a Normal A1c for Type 2 Children? Posted: Wednesday, April 15, 2009

According to the ADA and AACE, a normal A1c result is from 4-6%. Yet we know the closer you get to 6% means your average blood glucose is getting higher and increases your risk for pre-diabetes and diabetes.

Eat More, Move Less, and You Will Pay More Posted: Wednesday, April 15, 2009

To help cut medical costs, your insurance company may soon be raising premiums if you have unhealthy habits such as...

Liraglutide Has Low CVD Risk but May Be Blocked for Approval Posted: Wednesday, April 15, 2009

Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of animal studies linking the injection to thyroid cancer.

The Next DPP-4 Inhibitor Onglyza™ Passes CVD Review: Coming Soon Posted: Wednesday, April 15, 2009

An FDA panel voted 10-2 that the investigational diabetes drug saxagliptin (Onglyza) does not put Type 2 diabetes patients at an increased risk for cardiovascular events, but wants drugmaker Bristol-Myers Squibb to conduct long-term postmarketing studies to test the drug in older and sicker patients.

What You Drink Is More Important than What You Eat Posted: Wednesday, April 15, 2009

Researchers examined the relationship between beverage consumption among adults and weight change and found that weight loss was positively associated with a reduction in liquid calorie consumption and liquid calorie intake had a stronger impact on weight than solid calorie intake.

Understanding Barriers to Diabetes Self-Care Helps Providers Empower Patients Posted: Wednesday, April 15, 2009

Despite the provision of comprehensive management programs, patients are often unable to achieve the desired outcomes. It is essential to understand the barriers to diabetes self-care in order to promote successfully self-care behaviors."

Brown Fat Could Help Treat Obesity and Diabetes Posted: Friday, April 10, 2009

Brown fat, which helps use energy and burn calories, and was previously believed to only to exist in babies, has recently been shown to occur in adults as well. The discovery of the presence of this "good fat" in adults lays foundations for potential obesity and diabetes treatments that stimulate brown fat growth.

Sugar-Sweetened Beverages Responsible for Obesity Epidemic? Posted: Thursday, April 02, 2009

While diets often focus of solid caloric intake, a recent study has shown that decreasing intake of liquid calories may in fact be more effective in creating weight loss. Specifically, a reduction in sugar-sweetened beverage consumption could help prevent obesity and associated conditions, such as type 2 diabetes.

Fructose Triggers Increased Appetite Posted: Thursday, March 26, 2009

New research, which includes a meta-analysis of past research, stresses a link between fructose consumption and increased appetite. The resulting higher food intake that comes from consuming fructose, along with the recent rise in fructose-loaded products, gives reason to believe that fructose is at least partially responsible for rising obesity and type 2 diabetes rates, especially in youth. This is opposed to glucose, which in past research has been linked to decreased appetite.

Two New Diabetes Drugs could be Approved by April 2nd Posted: Thursday, March 26, 2009

A U.S. Food and Drug Administration panel will review two proposed drugs to treat Type 2 diabetes this April. According to a meeting notice posted on the FDA's website Monday, the FDA's Endocrinologic and Metabolic Drugs Advisory Committee will discuss Bristol-Myers Squibb's saxagliptin tablets on April 1 and Novo Nordisk.'s liraglutide injection on April 2.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.